Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
Lithium diisopropylamide → HCID 178455195, 화합물
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | Lithium diisopropylamide | HCID 2724682 | — |
| 반응물 | (2-Bromoethoxy)-tert-butyldimethylsilane | HCID 3608067 | — |
| 반응물 | tert-butyl 4-[[2-[[(2S)-2-bicyclo[2.2.1]heptanyl]amino]-5-methyl-4-oxo-1,3-thiazol-5-yl]methyl]piperidine-1-carboxylate | HCID 178451850 | — |
| 반응물 | 2-(2-bicyclo[2.2.1]heptanylamino)-5-[2-[tert-butyl(dimethyl)silyl]oxyethyl]-1,3-thiazol-4-one | HCID 178455202 | — |
| 생성물 | HCID 178455195 | HCID 178455195 | — |
반응 단계
The title compound was prepared according to the procedure described in the preparation of tert-butyl 4-((2-((2S)-bicyclo[2.2.1]heptan-2-ylamino)-5-methyl-4-oxo-4,5-dihydrothiazol-5-yl)methyl)piperidine-1-carboxylate by using 2-(bicyclo[2.2.1]heptan-2-ylamino)-5-(2-(tert-butyldimethylsilyloxy)ethyl)thiazol-4(5H)-one (630 mg, 1.71 mmol), lithium diisopropylamide (Aldrich, 2.0 M in heptane/THF/ethylbenzene, 4.27 mL, 8.55 mmol), and (2-bromoethoxy)(tert-butyl)dimethylsilane (Aldrich, 2.46 g, 10.25 mmol). The title compound was obtained as a sticky orange solid (771 mg). MS (ESI, pos. ion) m/z: 413 (M-TBDMS+2H).
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US08541592B2 |
| 출처 데이터셋 | uspto-grants-2013_09 |
| ORD ID | ord-6b5df5eb90b243ed9d0d8c270c613a6b |
| 출처 메모 | uspto-grants-2013_09 |